ACADIA Pharmaceuticals Inc.

ACAD · Healthcare · ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of medicines for neurological an…

ACADIA Pharmaceuticals Inc. (ACAD), in the Healthcare sector, has 8 disclosed filings on Paydirt over the trailing twelve months from 6 corporate insiders: 0 purchases and 8 sales. Filers took a median of 1 day from execution to disclosure, and the most recent trade was executed Aug 6 and filed Aug 7. The most active filer was Mark C. Schneyer with 4 filings.

Add to watchlist

Filings, ttm

0 buys · 8 sells

Traders, ttm

6 insiders

Volume, ttmiDollar value disclosed in the window

$2.8M

estimated for Congress, as filed for insiders

Median delay

execution to disclosure

Last traded

Aug 6

Filed Aug 7

ADViAverage daily dollar volume

$49.5M

market data

Share price · 12M

$28.90 (+17.8%)

Adjusted for splits and dividends.

Volume by month

Buys $0 Sells $4.0M

Estimated for Congress, as filed for insiders · by filing month · past 24 months

Who filed

Mark C. Schneyer EVP, CHIEF FINANCIAL OFFICER 4 filings JK

James Kihara PRINCIPAL ACCOUNTING OFFICER 2 filings LB

Laura Brege Director 1 filing JD

James M Daly Director 1 filing AO

Adams Catherine Owen Chief Executive Officer 1 filing JR

Jennifer J Rhodes EVP, CHIEF LEGAL OFFICER, SEC 1 filing BT

Brendan Teehan EVP, COO, HEAD OF COMMERCIAL 1 filing ET

Elizabeth H.Z. Thompson EVP, Head of Research & Dev 1 filing

Recent filings

Mark C. SchneyerSALE EVP, CHIEF FINANCIAL OFFICER $587K
20,141 sh across 3 lots
Exec Aug 5
Filed Aug 7 · 6:00 PM ET Elizabeth H.Z. ThompsonSALE EVP, Head of Research & Dev $431K
16,508 sh × $26.13
Exec Jul 30
Filed Jul 31 · 6:00 PM ET James KiharaSALE PRINCIPAL ACCOUNTING OFFICER $298K
11,421 sh × $26.08
Exec Jun 26
Filed Jun 29 · 5:30 PM ET James KiharaSALE PRINCIPAL ACCOUNTING OFFICER $114K
5,401 sh × $21.18
Exec May 26
Filed May 27 · 5:30 PM ET Adams Catherine OwenSALE Chief Executive Officer $250K
11,641 sh × $21.47
Exec Mar 25
Filed Mar 26 · 5:30 PM ET Jennifer J RhodesSALE EVP, CHIEF LEGAL OFFICER, SEC $162K
6,950 sh × $23.38
Exec Feb 9
Filed Feb 10 · 5:30 PM ET Mark C. SchneyerSALE EVP, CHIEF FINANCIAL OFFICER $243K
10,262 sh × $23.69
Exec Nov 18 2025
Filed Nov 19 2025 · 5:30 PM ET James M DalySALE Director $671K
30,000 sh × $22.37
Exec Nov 10 2025
Filed Nov 12 2025 · 5:30 PM ET Mark C. SchneyerSALE EVP, CHIEF FINANCIAL OFFICER $554K
22,000 sh × $25.18
Exec Aug 18 2025
Filed Aug 19 2025 · 5:30 PM ET Laura BregeSALE Director $315K
14,446 sh × $21.78
Exec Jun 4 2025
Filed Jun 5 2025 · 5:30 PM ET Mark C. SchneyerSALE EVP, CHIEF FINANCIAL OFFICER $172K
10,259 sh × $16.81
Exec Nov 19 2024
Filed Nov 19 2024 · 5:30 PM ET Brendan TeehanSALE EVP, COO, HEAD OF COMMERCIAL $174K
10,329 sh × $16.81
Exec Nov 19 2024
Filed Nov 19 2024 · 5:30 PM ET